|
Diabetes, Vol 48, Issue 9 1868-1872, Copyright © 1999 by American Diabetes Association
Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study
HH Lei, J Coresh, AR Shuldiner, E Boerwinkle and FL Brancati
Department of Epidemiology, the Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, USA.
We conducted a community-based case-control study of African-American men
and women in the Atherosclerosis Risk in Communities Study. The allele
frequencies of the Gly972Arg variant of the insulin receptor substrate-1
(IRS-1) gene and the Ala54Thr variant of the fatty acid binding protein 2
(FABP2) gene were compared in 992 normal control subjects and three patient
groups: 1) 321 type 2 diabetic individuals, 2) 260 severely obese
individuals, and 3) 258 markedly hyperinsulinemic individuals without
diabetes. Allele frequencies of Gly972Arg IRS-1 and Ala54Thr FABP2 were
0.07 and 0.22, respectively; there were no differences in allele or
genotype frequencies between patients and control subjects for either gene
variant. In weighted linear regression of all patients and control
subjects, the presence of the IRS-1 gene variant was associated with a 0.85
(0.42) kg/m2 higher BMI (P = 0.04). In addition, individuals with at least
one IRS-1 Arg972 allele and two FABP2 Thr54 alleles had a BMI of 33.3 (7.9)
kg/m2, compared with 30.0 (6.3) kg/m2 for those with neither allele (P =
0.05). These results suggest that in African-Americans, these variants in
the IRS-1 and FABP2 genes are not associated with the risk of type 2
diabetes, severe obesity, or marked hyperinsulinemia, but that their
independent and joint effects may be associated with small increases in
BMI.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Lara-Castro, G. R. Hunter, J. C. Lovejoy, B. A. Gower, and J. R. Fernandez
Association of the Intestinal Fatty Acid-Binding Protein Ala54Thr Polymorphism and Abdominal Adipose Tissue in African-American and Caucasian Women
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1196 - 1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Esposito, Y. Li, C. Vanni, S. Mammarella, S. Veschi, F. Della Loggia, R. Mariani-Costantini, P. Battista, M. J. Quon, and A. Cama
A Novel T608R Missense Mutation in Insulin Receptor Substrate-1 Identified in a Subject with Type 2 Diabetes Impairs Metabolic Insulin Signaling
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1468 - 1475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Weiss, M. D. Brown, A. R. Shuldiner, and J. M. Hagberg
Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects
Physiol Genomics,
September 3, 2002;
10(3):
145 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev.,
April 1, 2002;
23(2):
201 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M.N. Bezerra, V. de Castro, T. Sales, R. Passini Jr, S. T.M. Marba, S. T.O. Saad, and M. J.A. Saad
The Gly972Arg Polymorphism in Insulin Receptor Substrate-1 Is Associated With Decreased Birth Weight in a Population-Based Sample of Brazilian Newborns
Diabetes Care,
March 1, 2002;
25(3):
550 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rice, Y. C. Chagnon, L. Perusse, I. B. Borecki, O. Ukkola, T. Rankinen, J. Gagnon, A. S. Leon, J. S. Skinner, J. H. Wilmore, et al.
A Genomewide Linkage Scan for Abdominal Subcutaneous and Visceral Fat in Black and White Families: The HERITAGE Family Study
Diabetes,
March 1, 2002;
51(3):
848 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Garant, W.H. L. Kao, F. Brancati, J. Coresh, T. M. Rami, C. L. Hanis, E. Boerwinkle, and A. R. Shuldiner
SNP43 of CAPN10 and the Risk of Type 2 Diabetes in African-Americans: The Atherosclerosis Risk in Communities Study
Diabetes,
January 1, 2002;
51(1):
231 - 237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO
Defects of the insulin receptor substrate (IRS) system in human metabolic disorders
FASEB J,
October 1, 2001;
15(12):
2099 - 2111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Galluzzi, L. A. Cupples, J. B. Meigs, P. W.F. Wilson, E. J. Schaefer, and J. M. Ordovas
Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid-Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring Study
Diabetes Care,
July 1, 2001;
24(7):
1161 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Georgopoulos, O. Aras, and M. Y. Tsai
Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
September 1, 2000;
85(9):
3155 - 3160.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. L. Brancati, W. H. L. Kao, A. R. Folsom, R. L. Watson, and M. Szklo
Incident Type 2 Diabetes Mellitus in African American and White Adults: The Atherosclerosis Risk in Communities Study
JAMA,
May 3, 2000;
283(17):
2253 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|